Skip to content

Parainfluenza Virus Type 2 Antigen BA1262VS



  • Virion/Serion Immunologics Antigen for research use (RUO)
  • Parainfluenza Virus Type 2 Antigen, recombinant
  • Suitable for detection of IgA, IgG & IgM antibodies in ELISA
  • Lot specific concentration, specified in mg/mL
  • 1 mg
Weight1 lbs
Dimensions9 × 5 × 2 in

Parainfluenza Virus Type 2

species reactivity

Parainfluenza Virus



assay type

Indirect & quantitative

available size

1 mg

Available product – Parainfluenza Virus Type 2 Antigen BA1262VS

Research area
Infectious Disease
Store at -65°C or lower. Avoid repeated freeze-thaw cycles. Sonicate before use. 10 years from date of manufacture (under recommended storage conditions).
Associated products
Parainfluenza Virus Type 1 Antigen (BA1261VS)
Parainfluenza Virus Type 2 Antigen (BA1262VS)
Parainfluenza Virus Type 3 Control Antigen (BA1263VS)
Parainfluenza Virus Human IgA Assay Control (BC126A)
Parainfluenza Virus Human IgG Assay Control (BC126G)
Parainfluenza Virus IgA ELISA Kit (ESR126A)
Parainfluenza Virus IgG ELISA Kit (ESR126G)
target relevance
Parainfluenza Virus
Structure and strains
Human parainfluenza viruses (HPIVs) are the viruses that cause human parainfluenza. HPIVs are a paraphyletic group of four distinct single-stranded RNA viruses belonging to the Paramyxoviridae family. These viruses are closely associated with both human and veterinary disease. Virions are approximately 150 250 nm in size and contain negative sense RNA with a genome encompassing about 15,000 nucleotides.
Parainfluenza Viruses are worldwide distributed (-)ssRNA viruses belonging to the family of Paramyxoviridae. Currently, four serotypes have been identified. The Parainfluenza Virus types 1 to 3 are clinically most significant.

Human Parainfluenza Viruses are a common causative agent of infections of the respiratory tract, particularly in infants and children. Transmission of the viruses occurs by droplet infections. Parainfluenza Viruses cause mild to severe infections in the lower and upper respiratory tract which may manifest as rhinitis, cough, fever, non-diphtheric croup (acute laryngotracheobronchitis) or pneumonia. In infants, excessive formation of mucus and internal airway obstruction can occur. In adults, an infection usually results in mild catarrh of the upper respiratory tract.
Detection and diagnosis
While the majority of patients infected with Parainfluenza Viruses develop IgG antibodies, IgM antibodies are detectable in approximately 50% of cases. Thus, the specific detection of IgA antibodies should be performed analogous to other infectious diseases of the respiratory tract (e.g. Respiratory Syncytial Virus infections). Particularly in children under three years of age the combined use of IgG and IgA detection is recommended.



Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.



relevant to this product
BA1262VS protocol


Product data sheet


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.